Cargando…
Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier
BACKGROUND: Angiotensin and serotonin have been identified as inducers of cardiac hypertrophy. DNA polymorphisms at the genes encoding components of the angiotensin and serotonin systems have been associated with the risk of developing cardiovascular diseases, including left ventricular hypertrophy...
Autores principales: | Coto, Eliecer, Palacín, María, Martín, María, Castro, Mónica G, Reguero, Julián R, García, Cristina, Berrazueta, José R, Morís, César, Morales, Blanca, Ortega, Francisco, Corao, Ana I, Díaz, Marta, Tavira, Beatriz, Alvarez, Victoria |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907326/ https://www.ncbi.nlm.nih.gov/pubmed/20594303 http://dx.doi.org/10.1186/1479-5876-8-64 |
Ejemplares similares
-
Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy
por: Rodríguez Junquera, Manuel, et al.
Publicado: (2022) -
Characterization of Left Ventricular Non-Compaction Cardiomyopathy
por: Lorca, Rebeca, et al.
Publicado: (2020) -
Association of the Genetic Variation in the Long Non-Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy
por: Cuesta-Llavona, Elías, et al.
Publicado: (2022) -
Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011) -
Mitochondrial Transcription Factors TFA, TFB1 and TFB2: A Search for DNA Variants/Haplotypes and the Risk of Cardiac Hypertrophy
por: Alonso-Montes, Cristina, et al.
Publicado: (2008)